Novel plasmid-mediated resistance to ceftazidime of a clinical isolate of Klebsiella pneumoniae.
Walmsley
S L
SL
Department of Medicine, Mount Sinai Hospital, University of Toronto.
Kitching
D A
DA
Low
D E
DE
Simor
A E
AE
Brunton
J L
JL
D000328:Adult; D002442:Ceftazidime / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004352:Drug Resistance, Microbial; D006801:Humans; D007108:Immune Tolerance; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008826:Microbial Sensitivity Tests; D009503:Neutropenia / Q000188:drug therapy; D010957:Plasmids / Q000502:physiology*; D001618:beta-Lactamases / Q000096:biosynthesis*
D002442:Ceftazidime; D001618:beta-Lactamases; C034413:beta-lactamase TEM-1